<table border="single" frame="box" id="ID_9E22CAD3-2FC7-49F7-9C8B-E54A51DB4D5F" width="442.796" xmlns="urn:hl7-org:v3" xmlns:voc="urn:hl7-org:v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="ID_2663AF25-9832-45BD-B912-21DBFAEE2C44">Table 3 Study 2â€”Patient Status at 6 Months</caption>
<col width="35.772%"></col>
<col width="30.894%"></col>
<col width="33.333%"></col>
<tbody>
<tr id="ID_D3AF29C0-E643-4096-88DB-7F5E9B939914">
<td align="left" valign="top"></td>
<td align="center" valign="top">Sotalol Hydrochloride  (AF)</td>
<td align="center" valign="top">Placebo</td>
</tr>
<tr id="ID_6547D49A-AAB6-4EEB-B9D4-EB675AB7132A">
<td align="left" valign="middle">Randomized </td>
<td align="center" valign="middle">118</td>
<td align="center" valign="middle">114</td>
</tr>
<tr id="ID_AF282FBD-3AE3-4C69-A9C3-F9719DE51712">
<td align="left" valign="top">On treatment in NSR at 6 months without recurrence<footnote id="SPLSERV-1f052502-d964-3fb9-a5ec-8f7f8ace8225">Symptomatic or asymptomatic AFIB/AFL</footnote>
</td>
<td align="center" valign="top">45%</td>
<td align="center" valign="top">29%</td>
</tr>
<tr id="ID_48CAA590-E494-4B4B-93D4-3DE96CECD0B5">
<td align="left" valign="top">Recurrence<footnoteref idref="SPLSERV-1f052502-d964-3fb9-a5ec-8f7f8ace8225"></footnoteref>
<footnote id="SPLSERV-a90dca6d-bc51-a96d-7c36-9ce5b43ab7c8">Efficacy endpoint of Study 2; study treatment stopped.</footnote>
</td>
<td align="center" valign="top">49%</td>
<td align="center" valign="top">67%</td>
</tr>
<tr id="ID_43682224-3094-4099-8EAB-47CDAE035C33">
<td align="left" valign="top">D/C for AEs </td>
<td align="center" valign="top">6%</td>
<td align="center" valign="top">3%</td>
</tr>
<tr id="ID_59788BFB-CD6C-4A50-AA4F-7A67770F834D">
<td align="left" valign="top">Death </td>
<td align="center" valign="top"></td>
<td align="center" valign="top">1%</td>
</tr>
</tbody>
</table>